Clinical Trials for Mesothelioma Patients—Printed Education Materials in Patients Who Are Finishing Treatment for Cancer: Disease Characteristics

Read the disease characteristics for a current clinical trial to develop printed educational materials for patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Disease Characteristics:

• Diagnosis of breast, colorectal, prostate, or thoracic cancer* o Stage I-III disease o Approaching, attending, or already attended with the past 28 days, the last treatment appointment of chemotherapy and/or radiotherapy NOTE: *Stage IIIA disease for thoracic cancer and excluded mesothelioma; if small cell lung cancer is present must be limited stage disease
• No more than 1 primary cancer
• No recurrent disease
• Hormone receptor status not specified

Patient Characteristics:

• Male or female
• Menopausal status not specified
• Able to speak/read English at an 8th grade level

Prior Concurrent Therapy:

• See Disease Characteristics
• No prior brachytherapy only
• No prior surgery only (i.e., must have received prior adjuvant therapy and surgery)

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health